课题基金 / 基金详情

TREATMENT OF RHEUMATOID ARTHRITIS WITH ORAL BOVINE TYPE II CARTILAGE

TREATMENT OF RHEUMATOID ARTHRITIS WITH ORAL BOVINE TYPE II CARTILAGE
用牛口腔 II 型软骨治疗类风湿性关节炎
批准号：
6116823
负责人：
ARNOLD E POSTLETHWAITE
金额：
$0.0万
依托单位：
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
依托单位国家：
美国
项目类别：
财政年份：
1996
资助国家：
美国
项目状态：
已结题
起止时间：
1996-12-01 至 1999-08-14
来源：
https://reporter.nih.gov/project-details/6116823
关键词：
animal extract antiinflammatory agents clinical research clinical trials collagen drug screening /evaluation human subject human therapy evaluation immunopathology chemotherapy longitudinal human study oral administration outcomes research rheumatoid arthritis skeletal disorder chemotherapy

项目摘要

项目成果

ARNOLD E POSTLETHWAITE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this study is to test the hypothesis that orally administered soluble bovine type II collagen will decrease clinical signs and symptoms of RA and laboratory parameters characteristic of RA activity in patients whose disease is not controlled by DMARDs and/or nonsteroidal anti- inflammatory drug (NSAID) therapy. This is a double-blind, placebo- controlled trial involving 250 patients with active RA. Follow-up visits to assess any long-term effects will be made after another 6 months.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Vitamin D-Gelsolin-S1P Axis in Rheumatoid Arthritis
  • 批准号：
    9412753
  • 项目类别：
  • 资助金额：
    $0.0万
  • 财政年份：
    2016
  • 负责人：
    ARNOLD E POSTLETHWAITE
  • 依托单位：
    MEMPHIS VA MEDICAL CENTER
Mechanism of action of 20-hydroxyvitamin D3 in dermal fibroblasts
Chronic Sleep Restriction Increases Immunity to Autoantigen: Role of the SNS
Chronic Sleep Restriction Increases Immunity to Autoantigen: Role of the SNS
海外基金